LumiraDx (LumiraDx) Short-Term Capital Lease Obligation : $8.8 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Short-Term Capital Lease Obligation?

LumiraDx's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was $8.8 Mil.

LumiraDx's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 ($9.1 Mil) to Mar. 2023 ($8.5 Mil) but then increased from Mar. 2023 ($8.5 Mil) to Jun. 2023 ($8.8 Mil).

LumiraDx's annual Short-Term Capital Lease Obligation increased from Dec. 2020 ($2.1 Mil) to Dec. 2021 ($5.6 Mil) and increased from Dec. 2021 ($5.6 Mil) to Dec. 2022 ($9.1 Mil).

LumiraDx Short-Term Capital Lease Obligation Historical Data

The historical data trend for LumiraDx's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Short-Term Capital Lease Obligation Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Short-Term Capital Lease Obligation

2.11

5.58

9.15

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial								6.50	6.50	9.15	8.49	8.85

LumiraDx Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

LumiraDx Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of LumiraDx's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.